Literature DB >> 11203545

Human histologic evaluation of a bovine-derived bone xenograft in the treatment of periodontal osseous defects.

J T Mellonig1.   

Abstract

This study evaluated a bovine-derived bone xenograft (Bio-Oss) in the treatment of human periodontal osseous defects. Four patients with at least one tooth that had been recommended for extraction because of interproximal advanced periodontal disease volunteered to participate. The surgical procedure consisted of flap reflection, soft tissue debridement, placing a notch in calculus as a histologic reference point, root planing, placement of the bovine-derived xenograft and a bioresorbable physical barrier, and flap closure. Patients were seen every 2 weeks for plaque control and any necessary adjunctive treatment. At 4 to 6 months postsurgery, 6 teeth, along with the adjacent graft site, were removed en bloc. Histologic observations demonstrated new bone, new cementum, and new periodontal ligament coronal to the reference notch in 3 of the 4 specimens. This study indicates that periodontal regeneration is possible following grafting with a bovine-derived xenograft.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11203545

Source DB:  PubMed          Journal:  Int J Periodontics Restorative Dent        ISSN: 0198-7569            Impact factor:   1.840


  27 in total

1.  Five-year results of guided tissue regeneration in combination with deproteinized bovine bone (Bio-Oss) in the treatment of intrabony periodontal defects: a case series report.

Authors:  Andreas Stavropoulos; Thorkild Karring
Journal:  Clin Oral Investig       Date:  2005-07-12       Impact factor: 3.573

Review 2.  Gene therapeutics for periodontal regenerative medicine.

Authors:  Christoph A Ramseier; Zachary R Abramson; Qiming Jin; William V Giannobile
Journal:  Dent Clin North Am       Date:  2006-04

Review 3.  Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering.

Authors:  Eduardo K Moioli; Paul A Clark; Xuejun Xin; Shan Lal; Jeremy J Mao
Journal:  Adv Drug Deliv Rev       Date:  2007-04-18       Impact factor: 15.470

4.  Effect of pulverized natural bone mineral on regeneration of three-wall intrabony defects. A preclinical study.

Authors:  A Ivanovic; D D Bosshardt; I Mihatovic; F Schwarz; R Gruber; A Sculean
Journal:  Clin Oral Investig       Date:  2013-08-25       Impact factor: 3.573

5.  Clinical and Radiologic Evaluation of Regenerative Potential of NHA Paste and DBM in the Treatment of Periodontal Intra-bony Defects -A Randomized Control Trial.

Authors:  Deepti Jain; Anshul Sawhney; Bharat Gupta; Saurabh Sharma; Saurabh Juneja; Manjushree Juneja; Shruti Sharma; Neha Patil
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 6.  Advanced reconstructive technologies for periodontal tissue repair.

Authors:  Christoph A Ramseier; Giulio Rasperini; Salvatore Batia; William V Giannobile
Journal:  Periodontol 2000       Date:  2012-06       Impact factor: 7.589

7.  Formation of human cementum following different modalities of regenerative therapy.

Authors:  A Sculean; A Stavropoulos; M Berakdar; P Windisch; T Karring; M Brecx
Journal:  Clin Oral Investig       Date:  2005-01-06       Impact factor: 3.573

8.  GTR treatment of intrabony defects with PLA/PGA copolymer or collagen bioresorbable membranes in combination with deproteinized bovine bone (Bio-Oss).

Authors:  Andreas Stavropoulos; Anton Sculean; Thorkild Karring
Journal:  Clin Oral Investig       Date:  2004-08-03       Impact factor: 3.573

9.  MMP-9 and CD68(+) cells are required for tissue remodeling in response to natural hydroxyapatite.

Authors:  Willian F Zambuzzi; Katiúcia B S Paiva; Renato Menezes; Rodrigo C Oliveira; Rumio Taga; José M Granjeiro
Journal:  J Mol Histol       Date:  2009-11-22       Impact factor: 2.611

10.  Healing of human intrabony defects following regenerative periodontal therapy with a bovine-derived xenograft and guided tissue regeneration.

Authors:  A Sculean; A Stavropoulos; P Windisch; T Keglevich; T Karring; I Gera
Journal:  Clin Oral Investig       Date:  2004-02-06       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.